Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity
Open Access
- 1 October 2007
- journal article
- Published by Elsevier in Kidney International
- Vol. 72 (8) , 985-993
- https://doi.org/10.1038/sj.ki.5002467
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, β2-microglobulin, and N-acetyl-β-d-glucosaminidase in cadmium nonpolluted regions in JapanEnvironmental Research, 2006
- Serum Clara-Cell Protein and β2-Microglobulin as Early Markers of Occupational Exposure to Nitric OxidesInhalation Toxicology, 2005
- Increased Serum and Urinary Concentrations of Lung Clara Cell Protein in Rats Acutely Exposed to OzoneToxicology and Applied Pharmacology, 1999
- PURIFICATION AND CELLULAR LOCALIZATION OF β2-MICROGLOBULIN IN THE TESTISLife Sciences, 1997
- Role of Metallothionein in Cadmium-Induced Hepatotoxicity and NephrotoxicityDrug Metabolism Reviews, 1997
- Toxicological Principles of Metal Carcinogenesis with Special Emphasis on CadmiumCritical Reviews in Toxicology, 1992
- Non-metallothionein-bound cadmium in the pathogenesis of cadmium nephrotoxicity in the ratToxicology and Applied Pharmacology, 1989
- Significance of increase in urinary metallothionein of rats repeatedly exposed to cadmiumToxicology, 1986
- Antigenic, molecular and functional heterogeneity of Clara cell secretory proteins in the ratBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Cadmium in human populationCellular and Molecular Life Sciences, 1984